Calls
1
Lee Kyung-ho
CFO, Y-Biologics
Win Rate
-
return
-
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 15
$24000.00
-
Y-Biologics is developing a next-generation immuno-oncology platform that combines a PD-1 antibody, an optimized cytokine, and a bispecific third axis to address the roughly 70% of patients who do not respond to Keytruda. Management expects AACR abstracts and clinical/preclinical data to attract global pharma interest, and the research director has been buying shares as a confidence signal. The company believes this multi-cytokine approach can surpass current PD-1xVEGF bispecifics.
Other
Showing 1 of 1 calls · sorted by mentions
Choose a mentions count to open ticker posts.
Lee Kyung-ho has 1 trade ideas tracked on Buzzberg across 5 tickers since January 2026.
Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology
